Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 15-Sep 2021. Module: Belgian module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1932871000172112 | COVID-19 viral vector vaccine (JNJ-78436735( Ad26.COV2-S recombinant)) of Johnson and Johnson, Janssens | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1932891000172113 | COVID-19 viral vector vaccine (JNJ-78436735( Ad26.COV2-S recombinant)) of Johnson and Johnson, Janssens (medicinal product) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Belgian module (core metadata concept) |
| 9033271000172119 | COVID-19 vaccin à vecteur viral (JNJ-78436735(Ad26.COV2-S recombinant)) de Johnson et Johnson, Janssens | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Belgian module (core metadata concept) |
| 9033281000172116 | COVID-19 virale vectorvaccin (JNJ-78436735(Ad26.COV2-S recombinant)) van Johnson en Johnson, Janssens | nl | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| COVID-19 viral vector vaccine (JNJ-78436735( Ad26.COV2-S recombinant)) of Johnson and Johnson, Janssens | Is a | COVID-19 non-replicating viral vector vaccine | true | Inferred relationship | Some | ||
| COVID-19 viral vector vaccine (JNJ-78436735( Ad26.COV2-S recombinant)) of Johnson and Johnson, Janssens | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| COVID-19 viral vector vaccine (JNJ-78436735( Ad26.COV2-S recombinant)) of Johnson and Johnson, Janssens | Has supplier | Janssen Inc. | true | Inferred relationship | Some | ||
| COVID-19 viral vector vaccine (JNJ-78436735( Ad26.COV2-S recombinant)) of Johnson and Johnson, Janssens | Has active ingredient | Recombinant non-replicating human adenovirus 26 vector encoding severe acute respiratory syndrome coronavirus 2 spike protein | true | Inferred relationship | Some | 1 | |
| COVID-19 viral vector vaccine (JNJ-78436735( Ad26.COV2-S recombinant)) of Johnson and Johnson, Janssens | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| COVID-19 viral vector vaccine (JNJ-78436735( Ad26.COV2-S recombinant)) of Johnson and Johnson, Janssens | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
FHIR